AU2015327346B2 - Boronic acid derivatives - Google Patents
Boronic acid derivatives Download PDFInfo
- Publication number
- AU2015327346B2 AU2015327346B2 AU2015327346A AU2015327346A AU2015327346B2 AU 2015327346 B2 AU2015327346 B2 AU 2015327346B2 AU 2015327346 A AU2015327346 A AU 2015327346A AU 2015327346 A AU2015327346 A AU 2015327346A AU 2015327346 B2 AU2015327346 B2 AU 2015327346B2
- Authority
- AU
- Australia
- Prior art keywords
- ethyl
- amino
- boronic acid
- acetyl
- benzofuran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 C**(*)C(BO*)NC(*)=O Chemical compound C**(*)C(BO*)NC(*)=O 0.000 description 3
- KTMZFWKOEONFMX-ZDUSSCGKSA-N CCCC[C@@H](B(O)O)NC(Cc1ccc(C)cc1)=O Chemical compound CCCC[C@@H](B(O)O)NC(Cc1ccc(C)cc1)=O KTMZFWKOEONFMX-ZDUSSCGKSA-N 0.000 description 1
- RLTMNZXXWXRXBA-QRWMCTBCSA-N CO[C@@H](C(NC(B(O)O)Cc1c[o]c2c1cccc2)=O)c1ccccc1 Chemical compound CO[C@@H](C(NC(B(O)O)Cc1c[o]c2c1cccc2)=O)c1ccccc1 RLTMNZXXWXRXBA-QRWMCTBCSA-N 0.000 description 1
- SMTNZTWAINTFKB-PKHIMPSTSA-N Cc1c2OCC(C[C@@H](B(O)O)NC(Cc(cccc3)c3C(NC)=O)=O)c2ccc1 Chemical compound Cc1c2OCC(C[C@@H](B(O)O)NC(Cc(cccc3)c3C(NC)=O)=O)c2ccc1 SMTNZTWAINTFKB-PKHIMPSTSA-N 0.000 description 1
- PCXANDXAPPQYFH-SFHVURJKSA-N Cc1cc(C)c(C[C@@H](B(O)O)NC(Cc(cc2)ccc2NC)=O)cc1 Chemical compound Cc1cc(C)c(C[C@@H](B(O)O)NC(Cc(cc2)ccc2NC)=O)cc1 PCXANDXAPPQYFH-SFHVURJKSA-N 0.000 description 1
- GPSZLHTULIYHCH-UHFFFAOYSA-N Cc1ccc(C(C(NC(Cc2c[o]c3c2cccc3)S(O)O)=O)(F)F)cc1 Chemical compound Cc1ccc(C(C(NC(Cc2c[o]c3c2cccc3)S(O)O)=O)(F)F)cc1 GPSZLHTULIYHCH-UHFFFAOYSA-N 0.000 description 1
- SMYJZSFGQZDQGJ-CRAIPNDOSA-N Cc1ccc(CC(N[C@@H](B(O)O)C[C@H]2c3ccccc3OC2)=O)cc1 Chemical compound Cc1ccc(CC(N[C@@H](B(O)O)C[C@H]2c3ccccc3OC2)=O)cc1 SMYJZSFGQZDQGJ-CRAIPNDOSA-N 0.000 description 1
- GZGGBANFBHLMPU-QZTJIDSGSA-N Cc1cccc2c1[o]cc2C[C@H](B(O)O)NC([C@H](CO)c1ccccc1)=O Chemical compound Cc1cccc2c1[o]cc2C[C@H](B(O)O)NC([C@H](CO)c1ccccc1)=O GZGGBANFBHLMPU-QZTJIDSGSA-N 0.000 description 1
- BXHOGNGAVFOEGS-UHFFFAOYSA-N OB(C(Cc1cc2ccccc2[o]1)NC(Cc1ccccc1)=O)O Chemical compound OB(C(Cc1cc2ccccc2[o]1)NC(Cc1ccccc1)=O)O BXHOGNGAVFOEGS-UHFFFAOYSA-N 0.000 description 1
- DVKUEMBUVFXROO-UHFFFAOYSA-N OB(C(Cc1ccccc1)NC(COc1ncccc1)=O)O Chemical compound OB(C(Cc1ccccc1)NC(COc1ncccc1)=O)O DVKUEMBUVFXROO-UHFFFAOYSA-N 0.000 description 1
- XXWXENYIOFZZEN-FUHWJXTLSA-N OB([C@@H](Cc1c[o]c2ccccc12)NC([C@@H](CO)c1ccccc1)=O)O Chemical compound OB([C@@H](Cc1c[o]c2ccccc12)NC([C@@H](CO)c1ccccc1)=O)O XXWXENYIOFZZEN-FUHWJXTLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14003392 | 2014-10-01 | ||
| EP14003392.9 | 2014-10-01 | ||
| PCT/EP2015/002008 WO2016050359A1 (en) | 2014-10-01 | 2015-10-01 | Boronic acid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015327346A1 AU2015327346A1 (en) | 2017-05-18 |
| AU2015327346B2 true AU2015327346B2 (en) | 2019-12-05 |
Family
ID=51690789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015327346A Ceased AU2015327346B2 (en) | 2014-10-01 | 2015-10-01 | Boronic acid derivatives |
Country Status (14)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3201208B1 (en) | 2014-10-01 | 2021-03-24 | Merck Patent GmbH | Boronic acid derivatives |
| US10640520B2 (en) | 2014-10-01 | 2020-05-05 | Merck Patent Gmbh | Boronic acid derivatives |
| AU2015327345B9 (en) | 2014-10-01 | 2020-06-18 | Merck Patent Gmbh | Boronic acid derivatives |
| IL272806B2 (en) * | 2017-08-24 | 2023-09-01 | Merck Patent Gmbh | The history of boronic acid, its preparation and pharmaceutical preparations containing it |
| MX2021000214A (es) * | 2018-07-26 | 2021-03-31 | Merck Patent Gmbh | Derivados de acido boronico. |
| CN113135944A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| CN113135943A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| US20250340577A1 (en) * | 2021-03-02 | 2025-11-06 | Case Western Reserve University | Beta-lactomase inhibitors and uses thereof |
| AU2022277401B2 (en) * | 2021-05-19 | 2025-08-14 | Syngenta Crop Protection Ag | Weed control method |
| US20240287102A1 (en) | 2021-07-29 | 2024-08-29 | Merck Patent Gmbh | Novel crystalline forms of [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, adducts thereof, and processes to obtain |
| JP7734276B2 (ja) * | 2021-10-14 | 2025-09-04 | ショウヤオ ホールディングス（ベイジン） カンパニー， リミテッド | ボロン酸誘導体 |
| WO2023232830A1 (en) | 2022-06-02 | 2023-12-07 | Merck Patent Gmbh | Boronic acid adducts |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013092979A1 (en) * | 2011-12-22 | 2013-06-27 | Ares Trading S.A. | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| WO2001002424A2 (en) | 1999-07-07 | 2001-01-11 | Du Pont Pharmaceuticals Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
| US7271186B1 (en) | 2002-12-09 | 2007-09-18 | Northwestern University | Nanomolar β-lactamase inhibitors |
| EA201000774A1 (ru) * | 2007-11-13 | 2010-12-30 | Новартис Интернэшнл Фармасьютикл Лтд. | Ингибиторы бета-лактамазы |
| AR075090A1 (es) * | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
| EP3201208B1 (en) | 2014-10-01 | 2021-03-24 | Merck Patent GmbH | Boronic acid derivatives |
| US10640520B2 (en) | 2014-10-01 | 2020-05-05 | Merck Patent Gmbh | Boronic acid derivatives |
| AU2015327345B9 (en) | 2014-10-01 | 2020-06-18 | Merck Patent Gmbh | Boronic acid derivatives |
-
2015
- 2015-10-01 EP EP15780765.2A patent/EP3201207B1/en active Active
- 2015-10-01 ES ES15780765T patent/ES2873000T3/es active Active
- 2015-10-01 WO PCT/EP2015/002008 patent/WO2016050359A1/en not_active Ceased
- 2015-10-01 CN CN201580053425.1A patent/CN107001390B/zh not_active Expired - Fee Related
- 2015-10-01 CA CA2963205A patent/CA2963205A1/en active Pending
- 2015-10-01 RU RU2017115188A patent/RU2017115188A/ru not_active Application Discontinuation
- 2015-10-01 JP JP2017518100A patent/JP6835711B2/ja not_active Expired - Fee Related
- 2015-10-01 KR KR1020177011643A patent/KR102450583B1/ko not_active Expired - Fee Related
- 2015-10-01 AU AU2015327346A patent/AU2015327346B2/en not_active Ceased
- 2015-10-01 SG SG11201702623TA patent/SG11201702623TA/en unknown
- 2015-10-01 MX MX2017004046A patent/MX370336B/es active IP Right Grant
- 2015-10-01 BR BR112017006420A patent/BR112017006420A2/pt active Search and Examination
- 2015-10-01 US US15/516,424 patent/US10294246B2/en active Active
-
2017
- 2017-03-21 IL IL251301A patent/IL251301B/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013092979A1 (en) * | 2011-12-22 | 2013-06-27 | Ares Trading S.A. | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
Non-Patent Citations (1)
| Title |
|---|
| NESS STEVEN ET AL, "Structure-Based Design Guides the Improved Efficacy of Deacylation Transition State Analogue Inhibitors of TEM-1 .beta.-Lactamase", BIOCHEMISTRY, vol. 39, no. 18, pages 5312 - 5321 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2873000T3 (es) | 2021-11-03 |
| RU2017115188A (ru) | 2018-11-06 |
| AU2015327346A1 (en) | 2017-05-18 |
| SG11201702623TA (en) | 2017-04-27 |
| US20180105539A1 (en) | 2018-04-19 |
| CN107001390B (zh) | 2020-11-27 |
| RU2017115188A3 (cg-RX-API-DMAC10.html) | 2019-03-29 |
| JP2017536335A (ja) | 2017-12-07 |
| KR102450583B1 (ko) | 2022-10-04 |
| MX2017004046A (es) | 2017-06-19 |
| IL251301A0 (en) | 2017-05-29 |
| BR112017006420A2 (pt) | 2017-12-19 |
| EP3201207A1 (en) | 2017-08-09 |
| US10294246B2 (en) | 2019-05-21 |
| IL251301B (en) | 2022-02-01 |
| EP3201207B1 (en) | 2021-02-24 |
| MX370336B (es) | 2019-12-10 |
| WO2016050359A1 (en) | 2016-04-07 |
| CN107001390A (zh) | 2017-08-01 |
| KR20170062517A (ko) | 2017-06-07 |
| CA2963205A1 (en) | 2016-04-07 |
| JP6835711B2 (ja) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015327411B2 (en) | Boronic acid derivatives | |
| EP3201207B1 (en) | Boronic acid derivatives | |
| AU2015327412B2 (en) | Boronic acid derivatives | |
| AU2015327345B2 (en) | Boronic acid derivatives | |
| EP2793900A1 (en) | Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |